Followers | 826 |
Posts | 119435 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Monday, November 16, 2015 9:59:52 AM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABBV News
- Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis • PR Newswire (US) • 04/18/2024 12:31:00 PM
- AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine • PR Newswire (US) • 04/12/2024 11:30:00 AM
- SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne • PR Newswire (US) • 04/09/2024 12:00:00 PM
- AbbVie to Host First-Quarter 2024 Earnings Conference Call • PR Newswire (US) • 04/04/2024 12:00:00 PM
- Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting® • PR Newswire (US) • 04/03/2024 12:30:00 PM
- NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year • GlobeNewswire Inc. • 04/01/2024 11:50:00 AM
- Super Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest News • IH Market News • 03/26/2024 11:20:49 AM
- Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics • PR Newswire (US) • 03/25/2024 03:00:00 PM
- AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases • PR Newswire (US) • 03/25/2024 12:31:00 PM
- AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients • PR Newswire (US) • 03/22/2024 07:02:00 PM
- ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024 • PR Newswire (US) • 03/21/2024 12:00:00 PM
- AbbVie to Present at the Barclays 26th Annual Global Healthcare Conference • PR Newswire (US) • 03/07/2024 01:00:00 PM
- AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portfolios • PR Newswire (US) • 03/06/2024 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:30:50 PM
- Dragonfly a reçu un paiement d'étape à la suite de la prise de dose du premier patient à l'essai clinique de phase 1 d'AbbVie évaluant le DF4101/ABBV-303 • PR Newswire (Canada) • 03/05/2024 05:09:00 PM
- JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval • PR Newswire (US) • 03/05/2024 01:00:00 PM
- Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303 • PR Newswire (Canada) • 03/05/2024 12:00:00 PM
- Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303 • PR Newswire (US) • 03/05/2024 12:00:00 PM
- Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303 • PR Newswire (US) • 03/05/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:53:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:50:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:50:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:50:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:50:38 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM